Literature DB >> 23916100

The chromatin remodeller ATRX: a repeat offender in human disease.

David Clynes1, Douglas R Higgs, Richard J Gibbons.   

Abstract

The regulation of chromatin structure is of paramount importance for a variety of fundamental nuclear processes, including gene expression, DNA repair, replication, and recombination. The ATP-dependent chromatin-remodelling factor ATRX (α thalassaemia/mental retardation X-linked) has emerged as a key player in each of these processes. Exciting recent developments suggest that ATRX plays a variety of key roles at tandem repeat sequences within the genome, including the deposition of a histone variant, prevention of replication fork stalling, and the suppression of a homologous recombination-based pathway of telomere maintenance. Here, we provide a mechanistic overview of the role of ATRX in each of these processes, and propose how they may be connected to give rise to seemingly disparate human diseases. 2013 Elsevier Ltd. All rights reserved

Entities:  

Keywords:  ATRX; DNA replication; G4-quadruplex DNA; alternative lengthening of telomeres

Mesh:

Substances:

Year:  2013        PMID: 23916100     DOI: 10.1016/j.tibs.2013.06.011

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  53 in total

Review 1.  Mutant ATRX: uncovering a new therapeutic target for glioma.

Authors:  Santiago Haase; María Belén Garcia-Fabiani; Stephen Carney; David Altshuler; Felipe J Núñez; Flor M Méndez; Fernando Núñez; Pedro R Lowenstein; Maria G Castro
Journal:  Expert Opin Ther Targets       Date:  2018-06-20       Impact factor: 6.902

2.  ATRX directs binding of PRC2 to Xist RNA and Polycomb targets.

Authors:  Kavitha Sarma; Catherine Cifuentes-Rojas; Ayla Ergun; Amanda Del Rosario; Yesu Jeon; Forest White; Ruslan Sadreyev; Jeannie T Lee
Journal:  Cell       Date:  2014-11-06       Impact factor: 41.582

Review 3.  Mendelian disorders of the epigenetic machinery: tipping the balance of chromatin states.

Authors:  Jill A Fahrner; Hans T Bjornsson
Journal:  Annu Rev Genomics Hum Genet       Date:  2014       Impact factor: 8.929

4.  Viral reprogramming of the Daxx histone H3.3 chaperone during early Epstein-Barr virus infection.

Authors:  Kevin Tsai; Lilian Chan; Rebecca Gibeault; Kristen Conn; Jayaraju Dheekollu; John Domsic; Ronen Marmorstein; Luis M Schang; Paul M Lieberman
Journal:  J Virol       Date:  2014-10-01       Impact factor: 5.103

5.  Loss of ATRX Suppresses Resolution of Telomere Cohesion to Control Recombination in ALT Cancer Cells.

Authors:  Mahesh Ramamoorthy; Susan Smith
Journal:  Cancer Cell       Date:  2015-09-14       Impact factor: 31.743

Review 6.  Molecular Pathogenesis of Low-Grade Glioma.

Authors:  Devin Bready; Dimitris G Placantonakis
Journal:  Neurosurg Clin N Am       Date:  2019-01       Impact factor: 2.509

7.  Characterization of the Drosophila group ortholog to the amino-terminus of the alpha-thalassemia and mental retardation X-Linked (ATRX) vertebrate protein.

Authors:  Brenda López-Falcón; Silvia Meyer-Nava; Benjamín Hernández-Rodríguez; Adam Campos; Daniel Montero; Enrique Rudiño; Martha Vázquez; Mario Zurita; Viviana Valadez-Graham
Journal:  PLoS One       Date:  2014-12-01       Impact factor: 3.240

8.  A novel missense mutation in ATRX uncovered in a Yemeni family leads to alpha-thalassemia/mental retardation syndrome without alpha-thalassemia.

Authors:  A R Hamzeh; P Nair; M Mohamed; F Saif; N Tawfiq; M T Al-Ali; F Bastaki
Journal:  Ir J Med Sci       Date:  2016-02-09       Impact factor: 1.568

Review 9.  The epigenetics of stroke recovery and rehabilitation: from polycomb to histone deacetylases.

Authors:  Jessica Elder; Mar Cortes; Avrielle Rykman; Justin Hill; Saravanan Karuppagounder; Dylan Edwards; Rajiv R Ratan
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

Review 10.  Caught with One's Zinc Fingers in the Genome Integrity Cookie Jar.

Authors:  Caroline K Vilas; Lara E Emery; Eros Lazzerini Denchi; Kyle M Miller
Journal:  Trends Genet       Date:  2018-01-19       Impact factor: 11.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.